NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Corning is experienced in this field, but getting a useful cell product is another matter entirely.

mattpk,

Flaskworks has produced the MicroDEN® System for Dendritic Cell Generation and Corning entered into an agreement with Flaskworks to commercialize MicroDEN, an automated fluidic system that allows for differentiation of monocytes into DCs utilizing continuous perfusion of differentiation media.
https://www.genengnews.com/sponsored/automated-reproducible-dendritic-cell-production/

Flaskworks spun out of Northeastern University with a goal of improving the manufacture of autologous immunotherapeutics. Based in Boston, Massachusetts, Flaskworks collaborates with leading researchers who are developing lifesaving personalized treatments for cancer, autoimmune, and infectious diseases.

Flaskworks spun out of Northeastern University with a goal of improving the manufacture of autologous immunotherapeutics. Based in Boston, Massachusetts, Flaskworks collaborates with leading researchers who are developing lifesaving personalized treatments for cancer, autoimmune, and infectious diseases.
Autologous therapies utilize a patient’s own cells, thus each treatment must be individually manufactured introducing significant complexity to the process. With feedback from leading researchers, Flaskworks has developed a suite of systems that enable an automated, closed process for production of individualized treatment.

MicroDEN® System for Dendritic Cell Generation

• Generates up to 25 million dendritic cells per run from monocytes.
• Significantly reduces operator variability in monocyte-to-DC generation yield.
• Eliminates manual cell seeding, cytokine/medium refresh, and harvest.
• Major applications in biologics discovery & characterization (e.g. MLR assays), human, and non-human cells.
https://www.flaskworks.com/#contact

FLASKWORKS

about this project:

Problem

Due to the rise of personalized therapies, the demand for Dendritic cells has increased. However, the process for generating Dendritic cells has remained laborious, error-prone, and time intensive.

Solution

Flaskworks has produced a device, MicroDen, that revolutionizes the process. MicroDen is compact, easy-to-use, efficient, affordable, and 10x more productive than current methods and devices.

Leadership
President & CEO
Jennifer Rossi

Founder
Shashi Murthy

For more information about Flaskworks, contact Shashi Murthy.
https://www.northeastern.edu/cri/spinouts/flaskworks/